Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Circulation

• Publication date

  1989-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.79.4.948PMID 2924420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms. Effects of interventions that alter repolarization time.

  1990cited by this paper
• Nonuniform Epicardial Activation and Repolarization Properties of in Vivo Canine Pulmonary Conus

  1988cited by this paper
• Use dependence of amiodarone during the sinus tachycardia of exercise in coronary artery disease.

  1988cited by this paper
• Electrophysiologic effects of desethylamiodarone, an active metabolite of amiodarone: comparison with amiodarone during chronic administration in rabbits.

  1988cited by this paper
• Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel-blocking activity.

  1987cited by this paper
• Antiarrhythmic agents: modulated receptor applications.

  1987cited by this paper
• Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heart.

  1987cited by this paper
• Propagating depolarization in anisotropic human and canine cardiac muscle: apparent directional differences in membrane capacitance. A simplified model for selective directional effects of modifying the sodium conductance on Vmax, tau foot, and the propagation safety factor.

  1987cited by this paper
• Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite.

  1987cited by this paper
• Amiodarone-induced block of sodium current in isolated cardiac cells.

  1987cited by this paper
• Effects of Amiodarone and its Metabolite, Desethylamiodarone, on the Electrophysiologic Properties of Isolated Cardiac Muscle

  1986cited by this paper
• Cellular electrophysiology of amiodarone in cardiac ischaemia.

  1986cited by this paper
• Relating Extracellular Potentials and Their Derivatives to Anisotropic Propagation at a Microscopic Level in Human Cardiac Muscle: Evidence for Electrical Uncoupling of Side‐to‐Side Fiber Connections with Increasing Age

  1986cited by this paper
• Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.

  1986cited by this paper
• Effects of Antiarrhythmic Drugs on the Chronic Pacing Threshold and the Endocardial R Wave Amplitude in the Conscious Dog

  1986cited by this paper
• Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.

  1986cited by this paper
• The effects of procainamide on conduction in anisotropic canine ventricular myocardium.

  1986cited by this paper
• Acute effects of amiodarone on the electrophysiologic properties of isolated neonatal and adult cardiac fibers.

  1985cited by this paper
• Dispersion of ventricular repolarization and arrhythmia: study of two consecutive ventricular premature complexes.

  1985cited by this paper
• Frequency-dependent depression of myocardial contractility by slow calcium channel blocking drugs.

  1985cited by this paper
• Evidence for a Specific Receptor Site for Lidocaine, Quinidine, and Bupivacaine Associated with Cardiac Sodium Channels in Guinea Pig Ventricular Myocardium

  1985cited by this paper
• Effects of encainide on the determinants of cardiac excitability in sheep Purkinje fibers.

  1985cited by this paper
• Correlation between refractory periods and activation-recovery intervals from electrograms: effects of rate and adrenergic interventions.

  1985cited by this paper
• Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers.

  1985cited by this paper
• Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.

  1985cited by this paper
• Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart.

  1984cited by this paper
• Maximal Upstroke Velocity as an Index of Available Sodium Conductance: Comparison of Maximal Upstroke Velocity and Voltage Clamp Measurements of Sodium Current in Rabbit Purkinje Fibers

  1984cited by this paper
• Clinical Pharmacokinetics of Amiodarone

  1984cited by this paper
• Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs.

  1984cited by this paper
• Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone.

  1984cited by this paper
• Pharmacodynamics of Intravenous Amiodarone in the Dog

  1984cited by this paper
• Cable Properties and Conduction of the Action Potential

  1984cited by this paper
• Voltage- and use-dependent effects of lidocaine on sodium current in rat single ventricular cells.

  1983cited by this paper
• Myocardial disposition of amiodarone in the dog.

  1983cited by this paper
• Amiodarone pharmacokinetics.

  1983cited by this paper
• Amiodarone dosing: a proposal based on its pharmacokinetics.

  1983cited by this paper
• The Discontinuous Nature of Propagation in Normal Canine Cardiac Muscle: Evidence for Recurrent Discontinuities of Intracellular Resistance that Affect the Membrane Currents

  1981cited by this paper
• A simple technique for production of chronic complete heart block in dogs.

  1968cited by this paper

• Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study

  2023cites this paper
• CELLULAR ELECTROPHYSIOLOGICAL EFFECTS OF ANTIARRHYTHMIC DRUGS

  2019cites this paper
• Long-term amiodarone treatment causes cardioselective hypothyroid-like alteration in gene expression profile.

  2008cites this paper
• Frequency-Dependent Electrophysiologic Actions of Amiodarone and Sematilide in Humans

  2005cites this paper
• Amiodarone Combined With Class I Drugs TABLE 1 . Patients With Combined Antiarrhythmic Treatment and Responses in the Electrophysiology Studies Antiarrhythmic Electrophysiology combination test result Started Tested * Sustained VT Noninducible

  2005cites this paper
• Antiarrhythmic Drugs in Humans

  2005cites this paper
• Individual Patterns of Dynamic QT/RR Relationship in Survivors of Acute Myocardial Infarction and Their Relationship to Antiarrhythmic Efficacy of Amiodarone

  2004cites this paper
• Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study.

  2004cites this paper
• Differentially expressed genes in hypertensive rats developing cerebral ischemia.

  2004cites this paper
• Effect of Chronic Amiodarone Therapy on Excitable Gap During Typical Human Atrial Flutter

  2004cites this paper
• Combined Amiodarone and Silymarin Treatment, But Not Amiodarone Alone, Prevents Sustained Atrial Flutter in Dogs

  2003cites this paper
• Sympathetic Nervous System Activity and Ventricular Tachyarrhythmias: Recent Advances

  2003cites this paper
• Human Cardiac Repolarization

  2003cites this paper
• Chronic and Acute Effects of Dronedarone on the Action Potential of Rabbit Atrial Muscle Preparations: Comparison With Amiodarone

  2002cites this paper
• [Recent findings on the dromotropic actions of the class III antiarrhythmic agents].

  2002cites this paper
• A Review of Class III Antiarrhythmic Agents for Atrial Fibrillation: Maintenance of Normal Sinus Rhythm

  2001cites this paper
• Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone

  2001cites this paper
• Chronic Amiodarone Effects on Epicardial Conduction and Repolarization in the Isolated Porcine Heart

  2000cites this paper
• 第14回 犬山不整脈カンファランス メインテーマ 心不全治療薬と不整脈テーマI 「基礎」

  2000cites this paper
• Effect of Chronic Amiodarone Therapy on Defibrillation Energy Requirements in Humans

  2000cites this paper
• Potent and reversible effects of ATI-2001 on atrial and atrioventricular nodal electrophysiological properties in guinea pig isolated perfused heart.

  2000cites this paper
• Intravenous amiodarone in intensive care. Time for a reappraisal?

  2000cites this paper
• Anisotropic conduction prolongs ventricular repolarization and increases its spatial gradient in the intact canine heart.

  2000cites this paper
• QT interval and mortality from coronary artery disease.

  2000cites this paper
• Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.

  1999cites this paper
• Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone.

  1999cites this paper
• Heart rate and catecholamine contribution to qt interval shortening on exercise

  1999cites this paper
• Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent.

  1999cites this paper
• Changes in autonomic activity and ventricular repolarization.

  1999cites this paper
• Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.

  1999cites this paper
• Pharmacologic Therapy of Arrhythmias

  1999cites this paper
• KCB-328: a novel class III antiarrhythmic agent with little reverse frequency dependence in isolated guinea pig myocardium.

  1998cites this paper
• Effects of antiarrhythmic agents on junctional resistance of guinea pig ventricular cell pairs.

  1998cites this paper
• Comparative electrophysiologic findings between responders and nonresponders to class III antiarrhythmic drugs among patients with ventricular tachyarrhythmia.

  1998cites this paper
• Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.

  1998cites this paper
• Cellular electropharmacology of amiodarone.

  1997cites this paper
• Effects of long-term amiodarone treatment on ventricular-fibrillation vulnerability and defibrillation efficacy in response to monophasic and biphasic shocks.

  1997cites this paper
• Prolongation and spatial dispersion of local ventricular repolarization during anisotropic conduction in the intact canine hearts

  1997cites this paper
• Electrophysiologic effects of nibentan (HE-11) on canine cardiac tissue.

  1997cites this paper
• Rate-independent effects of the new class III antiarrhythmic agent ambasilide on transmembrane action potentials in human ventricular endomyocardium.

  1997cites this paper
• Comparison of the Rate‐Dependent Properties of the Class III Antiarrhythmic Agents Azimilide (NE‐10064) and E‐4031

  1997cites this paper
• Electrophysiological effects of a novel, short-acting and potent ester derivative of amiodarone, ATI-2001, in guinea pig isolated heart.

  1996cites this paper
• Effects of hypothyroidism on the Vulnerability to ventricular fibrillation in dogs: A comparative study with amiodarone

  1996cites this paper
• How to Measure AV Nodal Refractoriness in the Presence of Verapamil, Amiodarone, Digoxin, and Diltiazem

  1996cites this paper
• Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pig.

  1996cites this paper
• Toxicity of amiodarone on mouse pulmonary endothelial cells cultured with or without alveolar macrophages.

  1996cites this paper
• Electrophysiological, Rate Dependent, and Autonomic Effects of the Class III Antiarrhythmic Almokalant After Myocardial Infarction in the Pig

  1996cites this paper
• Acute and chronic effects of amiodarone on mammalian ventricular cells.

  1996cites this paper
• Effects of long-term oral administration of amiodarone on the ventricular repolarization of rabbit hearts.

  1996cites this paper
• Effects of class III antiarrhythmic drugs on the Na+‐activated K+ channels in guinea‐pig ventricular cells

  1996cites this paper
• Chronic in vivo and in vitro effects of amiodarone on guinea pig hearts.

  1996cites this paper
• Sudden Death During Flecainide Therapy for Atrial Fibrillation Complicating Wolff-Parkinson-White Syndrome

  1996cites this paper
• SR 33589, a New Amiodarone‐like Antiarrhythmic Agent: Electrophysiological Effects in Anesthetized Dogs

  1995cites this paper
• Use Dependence and Reverse Use Dependence of Antiarrhythmic Agents: Pro- and Antiarrhythmic Actions

  1995cites this paper
• Amiodarone: Reevaluation of an Old Drug

  1995cites this paper
• Antiarrhythmic Versus Proarrhythmic Effects of Class III Agents

  1995cites this paper
• Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs.

  1995cites this paper
• Basic Concepts in Cellular Cardiac Electrophysiology: Part II: Block of Ion Channels by Antiarrhythmic Drugs

  1995cites this paper
• Pharmacokinetics and regional electrophysiological effects of intracoronary amiodarone administration.

  1995cites this paper
• Electrophysiological Effects of SD‐3212, a Novel Antiarrhythmic Agent, on Rabbit Hearts In Vivo and In Vitro

  1995cites this paper
• Rate-dependent anisotropic conduction property in the epicardial border zone of canine myocardial infarcts and its modification by moricizine

  1995cites this paper
• Antiarrhythmic drug classifications and the clinician: A gambit in the land of chaos

  1994cites this paper
• Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for “reverse use dependent” block

  1994cites this paper
• [Methods of antiarrhythmic drug evaluation in man].

  1994cites this paper
• Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.

  1994cites this paper
• Classification and mechanism of action of antiarrhythmic drugs *

  1994cites this paper
• Rate-dependent effects of sematilide on action potential duration in isolated guinea pig ventricular myocytes.

  1994cites this paper
• Computer Aided Development of Antiarrhythmic Agents with Class IIIa Properties

  1994cites this paper
• Effects of amiodarone on the circadian rhythm and power spectral changes of heart rate and QT interval: significance for the control of sudden cardiac death.

  1994cites this paper
• Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents.

  1993cites this paper
• Frequency-dependent electrophysiologic effects of amiodarone in humans.

  1993cites this paper
• Radiofrequency versus pharmacologic modification of the atrioventricular node.

  1993cites this paper
• Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.

  1993cites this paper
• Use‐Dependent Prolongation of Ventricular Tachycardia Cycle Length by Type I Antiarrhythmic Drugs in Humans

  1993cites this paper
• Comparative mechanisms of action of antiarrhythmic drugs.

  1993cites this paper
• Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy.

  1993cites this paper
• K+channels and control of ventricular repolarization in the heart

  1993cites this paper
• Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact.

  1993cites this paper
• Potassium Channel Blockade as an Antiarrhythmic Principle

  1993cites this paper
• Rate‐dependence of class III actions in the heart

  1993cites this paper
• Reverse Use Dependence of Antiarrhythmic Class la, Ib, and Ic: Effects of Drugs on the Action Potential Duration?

  1992cites this paper
• A Quantitative Analysis of Use‐Dependent Ventricular Conduction Slowing by Procainamide in Anesthetized Dogs

  1992cites this paper
• Controlling Cardiac Arrhythmias by Lengthening Repolarization: Rationale from Experimental Findings and Clinical Considerations a

  1992cites this paper
• Frequency Dependent Effects of d‐Sotalol and Amiodarone on the Action Potential Duration of the Human Right Ventricle

  1992cites this paper
• Development of Class III Antiarrhythmic Agents

  1992cites this paper
• Effects of long‐term oral administration of amiodarone on the electromechanical performance of rabbit ventricular muscle

  1992cites this paper
• Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.

  1992cites this paper
• Antiarrhythmic Actions of DL‐Sotalol in Ventricular and Supraventricular Arrhythmias

  1992cites this paper
• [Ventricular repolarization].

  1992cites this paper
• Dofetilide, A Novel Class III Antiarrhythmic Agent

  1992cites this paper
• Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle

  1992cites this paper
• Suppression of Longitudinal Versus Transverse Conduction by Sodium Channel Block: Effects of Sodium Bolus

  1992cites this paper
• Electrophysiologic Effects of Ambasilide (LU 47110), a Novel Class III Antiarrhythmic Agent, on the Properties of Isolated Rabbit and Canine Cardiac Muscle

  1992cites this paper
• Kinetics of Use‐Dependent Ventricular Conduction Slowing by Antiarrhythmic Drugs in Humans

  1991cites this paper
• Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle.

  1991cites this paper
• A Prospective Comparison of Class IA, B, and C Antiarrhythmic Agents in Combination With Amiodarone in Patients With Inducible, Sustained Ventricular Tachycardia

  1991cites this paper
• The Use‐Dependent Effects of Acute and Chronic Amiodarone Administration on His‐Purkinje Conduction and the Interaction of β‐Adrenergic Stimulation

  1991cites this paper
• Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

  1990cites this paper
• Rate‐Dependent Class III Antiarrhythmic Action, Negative Chronotropy, and Positive Inotropy of a Novel Ik Blocking Drug, UK‐68,798: Potent in Guinea Pig but no Effect in Rat Myocardium

  1990cites this paper
• Relationship Between &OV0312;max and Conduction Velocity in Uniform Anisotropic Canine Ventricular Muscle: Differences Between the Effects of Lidocaine and Amiodarone

  1990cites this paper